Schrödinger
Venture capital · New York, New York, United States
Portfolio collected from the firm’s website.Raises and exits come from each company’s own SEC and company records.
5Deep-tech portfolio2 active
3Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Ajax Therapeutics
39Co-investorsShare a portfolio company
Portfolio · 5 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Kymera Therapeutics | Biotech | Active | — | — |
| Nimbus Therapeutics | Biotech | Active | — | — |
| Ajax Therapeutics | Biotech | Acquired | May 13, 2024 | $140.4M |
| Relay Therapeutics | Biotech | Public | Jan 10, 2024 | $30.0M |
| Vividion Therapeutics | Biotech | Acquired | Mar 2, 2021 | $240.7M |
Peer ranks
Portfolio size#81
Portfolio exits#69
Raises, 12 months#88
Co-investors#47
Co-investors
- RA CapitalVenture capital4 shared
- Biotechnology Value FundVenture capital3 shared
- Third Rock VenturesVenture capital3 shared
- Alexandria Venture InvestmentsVenture capital2 shared
- Apple Tree PartnersVenture capital2 shared
- Atlas VentureVenture capital2 shared
- Bay City CapitalVenture capital2 shared
- Boxer CapitalVenture capital2 shared
- EcoR1 CapitalVenture capital2 shared
- Logos CapitalVenture capital2 shared
Sectors
- Biotech5
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.